These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22473493)

  • 1. Covariate imbalance and precision in measuring treatment effects.
    Liu XS
    Eval Rev; 2011 Dec; 35(6):627-41. PubMed ID: 22473493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power?
    Hernández AV; Eijkemans MJ; Steyerberg EW
    Ann Epidemiol; 2006 Jan; 16(1):41-8. PubMed ID: 16275011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covariate adjustment in heart failure randomized controlled clinical trials: a case analysis of the HF-ACTION trial.
    O'Connor CM; Mentz RJ; Whellan DJ
    Heart Fail Clin; 2011 Oct; 7(4):497-500. PubMed ID: 21925432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline adjustments for binary data in repeated cross-sectional cluster randomized trials.
    Nixon RM; Thompson SG
    Stat Med; 2003 Sep; 22(17):2673-92. PubMed ID: 12939779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How large are the consequences of covariate imbalance in cluster randomized trials: a simulation study with a continuous outcome and a binary covariate at the cluster level.
    Moerbeek M; van Schie S
    BMC Med Res Methodol; 2016 Jul; 16():79. PubMed ID: 27401771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratification of randomization is not required for a pre-specified subgroup analysis.
    Kaiser LD
    Pharm Stat; 2013; 12(1):43-7. PubMed ID: 23281052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A priori power analysis in longitudinal three-level multilevel models: an example with therapist effects.
    de Jong K; Moerbeek M; van der Leeden R
    Psychother Res; 2010 May; 20(3):273-84. PubMed ID: 19946814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cluster size variability and imbalance in cluster randomized controlled trials.
    Carter B
    Stat Med; 2010 Dec; 29(29):2984-93. PubMed ID: 20963749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological issues of randomized controlled trials for the evaluation of reproductive health interventions.
    Villar J; Carroli G
    Prev Med; 1996; 25(3):365-75. PubMed ID: 8781015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive covariate adjustment in clinical trials.
    Wang SJ; Hung HM
    J Biopharm Stat; 2005; 15(4):605-11. PubMed ID: 16022166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjustment for baseline measurement error in randomized controlled trials induces bias.
    Chan SF; Macaskill P; Irwig L; Walter SD
    Control Clin Trials; 2004 Aug; 25(4):408-16. PubMed ID: 15296815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-parametric bounds on treatment effects with non-compliance by covariate adjustment.
    Cai Z; Kuroki M; Sato T
    Stat Med; 2007 Jul; 26(16):3188-204. PubMed ID: 17136775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating adjusted NNTs in randomised controlled trials with binary outcomes: a simulation study.
    Bender R; Vervölgyi V
    Contemp Clin Trials; 2010 Sep; 31(5):498-505. PubMed ID: 20624484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propensity scores: an introduction and experimental test.
    Luellen JK; Shadish WR; Clark MH
    Eval Rev; 2005 Dec; 29(6):530-58. PubMed ID: 16244051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal multivariate matching before randomization.
    Greevy R; Lu B; Silber JH; Rosenbaum P
    Biostatistics; 2004 Apr; 5(2):263-75. PubMed ID: 15054030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRINI: random group allocation of multiple prognostic factors.
    Kasturi J; Geisler JG; Liu J; Kirchner T; Amaratunga D; Lubomirski M
    Contemp Clin Trials; 2011 May; 32(3):372-81. PubMed ID: 21187163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional estimation and inference to address observed covariate imbalance in randomized clinical trials.
    Zhang Z; Tang L; Liu C; Berger VW
    Clin Trials; 2019 Apr; 16(2):122-131. PubMed ID: 30444129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.